Triazoloacridone C-1305 impairs XBP1 splicing by acting as a potential IRE1α endoribonuclease inhibitorSylwia Bartoszewska, Rafał Bartoszewski, Aneta Pogorzelska et al.|Cellular & Molecular Biology Letters|2021Cited by 18
Utilizing Genome-Wide mRNA Profiling to Identify the Cytotoxic Chemotherapeutic Mechanism of Triazoloacridone C-1305 as Direct Microtubule StabilizationJarosław Króliczewski, Rafał Bartoszewski, Ewa Sikora et al.|Cancers|2020Cited by 12
Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesisMarta Świtalska, Joanna Wietrzyk, Beata Filip‐Psurska et al.|Journal of Cellular and Molecular Medicine|2022Cited by 12
Symmetrically substituted carbazole derivatives exert antiproliferative effects through catalytic inhibition of topoisomerase II and apoptosis inductionMateusz Olszewski, Maciej Bagiński|Research Square|2023Cited by 1